{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:34:35Z","timestamp":1793410475960,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2025-NI-005-00"],"award-info":[{"award-number":["2025-NI-005-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154140","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:10:11Z","timestamp":1781651411000},"page":"154140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["HSP90 is involved in curcumin-mediated inhibition of tau aggregation"],"prefix":"10.1016","volume":"829","author":[{"given":"Min Kyoung","family":"Kam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Woong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9934-5321","authenticated-orcid":false,"given":"Young Ho","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulman","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154140_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154140_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbrc.2026.154140_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","article-title":"Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbrc.2026.154140_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","article-title":"A current view on Tau protein phosphorylation in Alzheimer's disease","volume":"69","author":"Wegmann","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbrc.2026.154140_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2008-14406","article-title":"Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments","volume":"14","author":"Brunden","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbrc.2026.154140_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbrc.2026.154140_bib7","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1038\/sj.emboj.7601917","article-title":"Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau","volume":"26","author":"Kimura","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2026.154140_bib8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3233\/JAD-160371","article-title":"Extracellular vesicles containing P301L mutant tau accelerate pathological tau phosphorylation and oligomer formation but do not seed mature neurofibrillary tangles in ALZ17 mice","volume":"54","author":"Baker","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbrc.2026.154140_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.154140_bib10","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","article-title":"Synaptic oligomeric tau in alzheimer's disease - a potential culprit in the spread of tau pathology through the brain","volume":"111","author":"Colom-Cadena","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2026.154140_bib11","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","article-title":"Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]","volume":"270","author":"Singh","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154140_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.2042-7158.1997.tb06761.x","article-title":"Nitric oxide scavenging by curcuminoids","volume":"49","author":"Sreejayan","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154140_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12035-011-8181-5","article-title":"Modulation of Nrf2\/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders","volume":"44","author":"Scapagnini","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2026.154140_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/srep18736","article-title":"Curcumin modulates cell death and is protective in Huntington's disease model","volume":"6","author":"Chongtham","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154140_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061975","article-title":"Curcumin in health and diseases: alzheimer's disease and curcumin analogues, derivatives, and hybrids","volume":"21","author":"Chainoglou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154140_bib16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-170512","article-title":"Protective effects of Indian spice curcumin against amyloid-beta in Alzheimer's disease","volume":"61","author":"Reddy","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbrc.2026.154140_bib17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2174\/1570159X18666200522201123","article-title":"Therapeutic and mechanistic effects of curcumin in Huntington's disease","volume":"19","author":"Labanca","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbrc.2026.154140_bib18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0269881114552744","article-title":"Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population","volume":"29","author":"Cox","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbrc.2026.154140_bib19","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1017\/S0007114516001203","article-title":"Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults","volume":"115","author":"Rainey-Smith","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbrc.2026.154140_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jagp.2017.10.010","article-title":"Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: a double-blind, placebo-controlled 18-Month trial","volume":"26","author":"Small","year":"2018","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.bbrc.2026.154140_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","article-title":"Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease","volume":"28","author":"Baum","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbrc.2026.154140_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/alzrt146","article-title":"Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study","volume":"4","author":"Ringman","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbrc.2026.154140_bib23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbrc.2026.154140_bib24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-170351","article-title":"Curcumin inhibits tau aggregation and disintegrates preformed tau filaments in vitro","volume":"60","author":"Rane","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbrc.2026.154140_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063401","article-title":"Chaperones-A new class of potential therapeutic targets in Alzheimer's Disease","volume":"25","author":"Batko","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154140_bib26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cell.2014.01.037","article-title":"Hsp90-Tau complex reveals molecular basis for specificity in chaperone action","volume":"156","author":"Karagoz","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.154140_bib27","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1074\/jbc.M112.393751","article-title":"Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice","volume":"288","author":"Ma","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154140_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax6999","article-title":"The mechanism of Hsp90-induced oligomerizaton of Tau","volume":"6","author":"Weickert","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2026.154140_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154140_bib30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fnins.2017.00724","article-title":"Imbalances in the Hsp90 chaperone machinery: implications for tauopathies","volume":"11","author":"Shelton","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrc.2026.154140_bib31","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/cb3002478","article-title":"Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate","volume":"7","author":"Hall","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.154140_bib32","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1038\/ncomms4496","article-title":"Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52","volume":"5","author":"Jo","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154140_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1021\/acschembio.5b00758","article-title":"Self-assembling NanoLuc luciferase fragments as probes for protein aggregation in living cells","volume":"11","author":"Zhao","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.154140_bib34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/33934","article-title":"Dynamic activation of endothelial nitric oxide synthase by Hsp90","volume":"392","author":"Garcia-Cardena","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154140_bib35","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1038\/s41598-021-87225-8","article-title":"Curcumin activates Nrf2 through PKCdelta-mediated p62 phosphorylation at Ser351","volume":"11","author":"Park","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154140_bib36","article-title":"Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154140_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pneurobio.2010.10.006","article-title":"Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease","volume":"93","author":"Salminen","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbrc.2026.154140_bib38","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1172\/JCI29715","article-title":"The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins","volume":"117","author":"Dickey","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154140_bib39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41420-021-00743-2","article-title":"The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells","volume":"7","author":"Park","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbrc.2026.154140_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijpharm.2011.06.030","article-title":"Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration","volume":"416","author":"Tsai","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2026.154140_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jnen\/nlac034","article-title":"The effect of curcumin on idiopathic parkinson disease: a clinical and skin Biopsy study","volume":"81","author":"Donadio","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbrc.2026.154140_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.conb.2018.04.027","article-title":"Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease","volume":"51","author":"Tracy","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbrc.2026.154140_bib43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddh083","article-title":"CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation","volume":"13","author":"Petrucelli","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2026.154140_bib44","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2026.154140_bib45","series-title":"Curcumin Modulates Molecular Chaperones and autophagy-lysosomal Pathways, Vitro","author":"Maiti","year":"2017"},{"key":"10.1016\/j.bbrc.2026.154140_bib46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1248\/bpb.30.74","article-title":"Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives","volume":"30","author":"Somparn","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrc.2026.154140_bib47","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1007\/s12035-023-03821-x","article-title":"Hexahydrocurcumin attenuates neuronal injury and modulates synaptic plasticity in chronic cerebral hypoperfusion in rats","volume":"61","author":"Jearjaroen","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2026.154140_bib48","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.str.2004.03.020","article-title":"The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site","volume":"12","author":"Harris","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.bbrc.2026.154140_bib49","doi-asserted-by":"crossref","first-page":"35386","DOI":"10.1074\/jbc.M703844200","article-title":"Dimerization of Hsp90 is required for in vivo function. Design and analysis of monomers and dimers","volume":"282","author":"Wayne","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154140_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.csbj.2014.09.011","article-title":"Cell-based models to investigate Tau aggregation","volume":"12","author":"Lim","year":"2014","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bbrc.2026.154140_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2121-12-23","article-title":"Immortalized cells and one oncogene in malignant transformation: old insights on new explanation","volume":"12","author":"Kavsan","year":"2011","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154140_bib52","first-page":"3751","article-title":"Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones","volume":"38","author":"Biedler","year":"1978","journal-title":"Cancer Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26009046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26009046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:00:03Z","timestamp":1786626003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26009046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"alternative-id":["S0006291X26009046"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154140","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HSP90 is involved in curcumin-mediated inhibition of tau aggregation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154140"}}